Efficacy and effectiveness trials

Community Oncology

Volumn 6, Issue 10, 2009, Pages 472-474

  Streiner, David L ^a   Norman, Geoffrey R ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER THERAPY; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; HEALTH CARE POLICY; HEART DEATH; HUMAN; INTERVENTION STUDY; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL RESEARCH; MORBIDITY; PATIENT SELECTION; PERIOPERATIVE PERIOD; SHORT SURVEY;

EID: 70350488641     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1548-5315(11)70286-8     Document Type: Short Survey

References (6)

1. Streiner DL. The two "e's" of research: efficacy and effectiveness trials. Can J Psychiatry 2002;47:552-556.
2. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutic trials. J Chronic Dis 1967;20:637-648.
3. The Lipid Research Clinics Coronary Primary Prevention Trial results: I. reduction in incidence of coronary heart disease. JAMA 1984;251:351-364.
4. Streiner DL. The case of the missing data: methods of dealing with dropouts and other research vagaries. Can J Psychiatry 2002;47:68-75.
5. Streiner DL. Missing data and the trouble with LOCF. Evid Based Ment Health 2008;11:3-5.
6. Weisz JR, Donenberg GR, Han SS, Weiss B. Bridging the gap between laboratory and clinic in child and adolescent psychotherapy. J Consult Clin Psychol 1995;63:688-701.